New screening tool aims to break the silence on sexual health after childhood cancer

NCT ID NCT05524610

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a simple questionnaire to help doctors identify sexual health concerns in teenagers and young adults who have or had childhood cancer. The goal is to improve communication between patients and providers. About 205 participants aged 15-24 will use the screening tool during clinic visits, and researchers will measure whether it leads to more discussions about sexual function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Sexual function screening questionnaire (PROMIS SexFS Brief)
What this could lead to
If successful, this screening approach could become a standard way for doctors to identify and discuss sexual health issues with young cancer survivors, leading to better support and quality of life.
What could go wrong
This is a small, early-stage study focused on feasibility and communication, not on treating sexual dysfunction. The screening tool may not work well in all clinic settings or for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Childrens Hospital Colorado

    RECRUITING

    Aurora, Colorado, 80045, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Colorado Hospital

    RECRUITING

    Aurora, Colorado, 80045, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.